Key result
Delivery of let-7i to mice significantly inhibited angiotensin II-induced cardiac inflammation and fibrosis in a dose-dependent manner by suppressing interleukin-6 and multiple collagens.
Why the study?
Does let-7i delivery reduce angiotensin II-induced cardiac inflammation and fibrosis in mouse models?
Does let-7i delivery reduce angiotensin II-induced cardiac inflammation and fibrosis in mouse models?
Let-7i acts as a novel negative regulator of angiotensin II-induced cardiac inflammation and fibrosis, representing a potential therapeutic target.
Let-7i attenuates angiotensin II-induced cardiac inflammation and fibrosis in mice; leaves open therapeutic translation to human hypertensive heart disease.
Angiotensin II stimulates fibroblast proliferation and substantially alters gene expression patterns leading to cardiac remodeling, but the mechanisms for such differences are unknown. MicroRNAs are a novel mechanism for gene expression regulation. Herein, we tested the miRNA and mRNA expression patterns in mouse heart using microarray assay and investigated their role in angiotensin II-induced cardiac remodeling. We found that let-7i was dynamically downregulated in angiotensin II-infused heart at day 3 and 7 and had the most targets that were mainly associated with cardiac inflammation and fibrosis. Overexpression or knockdown of let-7i in cultured cardiac fibroblasts demonstrated that let-7i played an inhibitory effect on the expression of its targets interleukin-6 and collagens. Furthermore, delivery of let-7i to mouse significantly inhibited angiotensin II-induced cardiac inflammation and fibrosis in a dose-dependent manner. Conversely, knockdown of let-7i aggravated this effect. Together, our results clearly demonstrate that let-7i acts as a novel negative regulator of angiotensin II-induced cardiac inflammation and fibrosis by suppressing the expression of interleukin-6 and multiple collagens in the heart and may represent a new potential therapeutic target for treating hypertensive cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2015) studied Angiotensin II-induced cardiac remodeling. let-7i delivery/overexpression vs. let-7i knockdown or control was evaluated on Cardiac inflammation and fibrosis (expression of interleukin-6 and collagens). Delivery of let-7i to mice significantly inhibited angiotensin II-induced cardiac inflammation and fibrosis in a dose-dependent manner by suppressing interleukin-6 and multiple collagens.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: